Assessing the regression of Barrett esophagus: Don't try it at home

Robert M. Genta

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


The discovery of a therapy to induce regression of intestinal metaplasia is one of the main objectives of clinical research in Barrett esophagus. As acid-control drugs have proved ineffective for this purpose, current interest is focused on antireflux surgery, particularly fundoplication. Several studies, including the one discussed in this commentary, have reported regression metaplasia and the absence of progression to high-grade dysplasia or adenocarcinoma after successful fundoplication, suggesting that this procedure is an effective approach for the management of patients with Barrett esophagus. The crucial question whether regression and absence of progression will result in the prevention of Barrett-associated adenocarcinoma may be answered by long-term follow-up of operated patients.

Original languageEnglish (US)
Pages (from-to)127-130
Number of pages4
JournalAdvances in anatomic pathology
Issue number3
StatePublished - May 1 2006


  • Barrett esophagus-intestinal metaplasia
  • Esophageal adenocarcinoma
  • Fundoplication
  • Regression

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine


Dive into the research topics of 'Assessing the regression of Barrett esophagus: Don't try it at home'. Together they form a unique fingerprint.

Cite this